Catalyst Wire Dossier Catalyst Wire Dossier

Yiqi Huoxue Jiedu Formula

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Yiqi Huoxue Jiedu Formula, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli [EARLY_Phase 1]

See pricing